Results 21 to 30 of about 12,722 (175)

Invasive meningococcal disease and travel

Journal of Infection and Public Health, 2010
Summary: The epidemiology of invasive meningococcal disease varies geographically and in time and the risk of acquiring the disease varies regionally, as well as with living conditions and behavior.
Ziad A. Memish, Anette Goubeaud, Michael Bröker, Claudius Malerczyk, Atef M. Shibl   +4 more
doaj   +1 more source

Meningococcal septicaemia reported in an immunocompetent adult: A Case Report

Sri Lankan Journal of Infectious Diseases, 2020
Meningococcal meningitis is caused by the Gram negative diplococcus, Neisseria meningitidis. It is characterized by nonspecific symptoms of fever and constitutional symptoms followed by septic shock   and meningitis.
S. Puthra, P. Selladurai, N. S. Chandrasiri, A. G. H. Sugathapala   +3 more
doaj   +1 more source

Socio-Cultural Factors Influencing the Perception and Management of Meningitis among Older Patients and Their Caregivers

Journal of Ageing and Longevity, 2022
Limited studies have investigated the socio-cultural factors influencing the management and control of Meningococcal Meningitis among older adults in Northern Nigeria.
Kafayat Mahmoud, Moshood Issah, Darlingtina Esiaka   +2 more
doaj   +1 more source

Assessing the Impact of TLR4 rs4986790 Polymorphism on Bacterial Meningitis Risk: A Systematic Review and Meta-Analysis

Annals of Indian Academy of Neurology
Background and Objectives: Toll-like receptor (TLR2) gene plays an important role in the pathogenesis of bacterial meningitis (such as meningococcal meningitis and pneumococcal meningitis).
Praveen Kumar Chandra Sekar, Ramakrishnan Veerabathiran   +1 more
doaj   +1 more source

Systemic manifestations in the course of meningococcal disease [PDF]

Vojnosanitetski Pregled, 2009
Background/Aim. Meningococcal disease most often manifests itself as meningitis or sepsis. During the course of these diseases, other clinical events sometimes develop such as pneumonia, pericarditis, arthritis, and they are referred to as extrameningeal
Dulović Olga, Stevanović Goran, Milošević Branko, Gvozdenović Eleonora, Dokić Ljubiša, Popović Nataša, Nikolić Svetlana, Pavlović Milorad   +7 more
doaj   +1 more source

Meningococcal Serogroup Y Meningitis Reveals Inborn Factor B Deficiency. [PDF]

Eur J Immunol
We report a novel case of complete complement Factor B deficiency revealed by invasive meningococcal disease. Using combined functional and genetic analyses, we demonstrate that loss of Factor B abolishes alternative pathway activity despite detectable protein levels. These findings provide a mechanistic framework relevant to complement diagnostics and
Bougeard C, Eskander E, Martins PV, Bitan J, Roquigny J, Kyheng C, Guiddir T, Frémeaux-Bacchi V, Gonnin C, ElSissy C.   +9 more
europepmc   +2 more sources

A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.

PLoS ONE, 2016
The pattern of epidemic meningococcal disease in the African meningitis belt may be influenced by the background level of population immunity but this has been measured infrequently.
Olivier Manigart, Caroline Trotter, Helen Findlow, Abraham Assefa, Wude Mihret, Tesfaye Moti Demisse, Biruk Yeshitela, Isaac Osei, Abraham Hodgson, Stephen Laryea Quaye, Samba Sow, Mamadou Coulibaly, Kanny Diallo, Awa Traore, Jean-Marc Collard, Rahamatou Moustapha Boukary, Oumarou Djermakoye, Ali Elhaji Mahamane, Jean-François Jusot, Cheikh Sokhna, Serge Alavo, Souleymane Doucoure, El Hadj Ba, Mariétou Dieng, Aldiouma Diallo, Doumagoum Moto Daugla, Babatunji Omotara, Daniel Chandramohan, Musa Hassan-King, Maria Nascimento, Arouna Woukeu, Ray Borrow, James M Stuart, Brian Greenwood   +33 more
doaj   +1 more source

Meningococcal purpura fulminans and severe myocarditis with clinical meningitis but no meningeal inflammation: a case report

BMC Infectious Diseases, 2019
Background During fulminant meningococcal septicaemia, meningococci are often observed in the cerebrospinal fluid (CSF) although the patients have frequently no meningeal symptoms.
Mehdi Hage-Sleiman, Nicolas Derre, Charlotte Verdet, Gilles Pialoux, Olivier Gaudin, Patricia Senet, Muriel Fartoukh, Mathieu Boissan, Marc Garnier   +8 more
doaj   +1 more source

Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges

Human Vaccines & Immunotherapeutics, 2018
Africa historically has had the highest incidence of meningococcal disease with high endemic rates and periodic epidemics. The meningitis belt, a region of sub-Saharan Africa extending from Senegal to Ethiopia, has experienced large, devastating ...
Mustapha M. Mustapha, Lee H. Harrison
doaj   +1 more source

Bacterial Meningitis in Brazil: Baseline Epidemiologic Assessment of the Decade Prior to the Introduction of Pneumococcal and Meningococcal Vaccines.

PLoS ONE, 2013
BackgroundBacterial meningitis is associated with significant burden in Brazil. In 2010, both 10-valent pneumococcal conjugate vaccine and meningococcal capsular group C conjugate vaccine were introduced into the routine vaccination schedule. Haemophilus
Luciano Cesar Pontes Azevedo, Cristiana M Toscano, Ana Luiza Bierrenbach   +2 more
doaj   +1 more source